Gs 6201

Gs 6201

SCHEMBL29504136

CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA2B

The experimentally established mechanism targets of Gs 6201. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADORA2B known ✓ P29275 20/20 1.00
ADORA2A P29274 18/20 1.00
ADORA1 P30542 17/20 1.00
ADORA3 P0DMS8 12/20 1.00
PLK4 O00444 1/20 1.00
CDK2 P24941 1/20 1.00
IRAK1 P51617 1/20 1.00
RPS6KA3 P51812 1/20 1.00
PLK3 Q9H4B4 1/20 1.00
CSNK1G3 Q9Y6M4 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gs 6201 SCHEMBL29504137 1.00 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3PLK4
Gs 6201 SCHEMBL29504138 1.00 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3PLK4
Gs 6201 SCHEMBL238694 1.00 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3PLK4
Gs 6201 SCHEMBL29504135 1.00 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3PLK4
SCHEMBL242517 0.97 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3PLK4
SCHEMBL1944742 0.95 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3PLK4
SCHEMBL243037 0.93 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3PLK4
SCHEMBL243736 0.90 ADORA2B (0.86) ADORA2BADORA2AADORA1ADORA3PLK4
SCHEMBL1944731 0.90 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3PLK4
SCHEMBL2685809 0.90 ADORA2B (0.85) ADORA2BADORA2AADORA1ADORA3PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4211135-A1 COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST Teon Therapeutics, Inc. (US) 2023-07-19 EP claimed
WO-2022051589-A1 COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST TEON THERAPEUTICS, INC. (US) 2022-03-10 WO claimed
EP-4211135-A1 COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST Teon Therapeutics, Inc. (US) 2023-07-19 EP disclosed
WO-2022051589-A1 COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST TEON THERAPEUTICS, INC. (US) 2022-03-10 WO disclosed